Prognostic factors in low tumour mass asymptomatic multiple myeloma: A report on 91 patients
- 1 February 1995
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 48 (2), 71-75
- https://doi.org/10.1002/ajh.2830480201
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- VAD or VMBCP in severe multiple myelomaBritish Journal of Haematology, 1992
- Incidence and follow‐up of asymptomatic multiple myeloma.European Journal of Haematology, 1991
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and stagingBritish Journal of Haematology, 1982
- A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patientsBlood, 1980
- Prognostic Factors in Multiple MyelomaActa Haematologica, 1978
- Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocolAmerican Journal Of Medicine, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Asymptotically Efficient Rank Invariant Test ProceduresJournal of the Royal Statistical Society. Series A (General), 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958